It was reported to boston scientific corporation that a xenform device was used during a pelvic floor repair procedure performed on (b)(6), 2014.The patient was discharged home on (b)(6), 2014.According to the complainant, on (b)(6), 2014, the patient visited the office and reported vaginal discharge and strong smelling urine, as well as a fever of 101.5f at home despite being on cipro.The patient¿s white blood cell count was elevated, and she was admitted to the hospital and treated with levaquin 500mg iv qd.The next day, the patient felt better, her white blood cell count was normal, and her urine had cleared up.Blood cultures, urine cultures and vaginal cultures were all negative.No diagnosis was made.The investigator assessed the fever as a "severe" serious adverse event that resulted in prolonged hospitalization.The event was assessed as related to the pelvic floor with a possible relationship to the index procedure but not device related.The event resolved on (b)(6), 2014.
|